Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
July 30, 2023 at 06:45 pm EDT
Share
Universal Biosensors, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was AUD 1.3 million compared to AUD 1.36 million a year ago. Net income was AUD 1.4 million compared to net loss of AUD 4.65 million a year ago. Basic earnings per share from continuing operations was AUD 0.01 compared to basic loss per share from continuing operations of AUD 0.02 a year ago. Diluted earnings per share from continuing operations was AUD 0.01 compared to diluted loss per share from continuing operations of AUD 0.02 a year ago.
For the six months, revenue was AUD 2.6 million compared to AUD 3.08 million a year ago. Net loss was AUD 2.39 million compared to AUD 9.18 million a year ago. Basic loss per share from continuing operations was AUD 0.01 compared to AUD 0.05 a year ago. Diluted loss per share from continuing operations was AUD 0.01 compared to AUD 0.05 a year ago.
Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.
UNIVERSAL BIOSENSORS, INC. 
